132 related articles for article (PubMed ID: 9639527)
1. The evolution of B precursor leukemia in the Emu-ret mouse.
Wasserman R; Zeng XX; Hardy RR
Blood; 1998 Jul; 92(1):273-82. PubMed ID: 9639527
[TBL] [Abstract][Full Text] [Related]
2. The fetal origin of B-precursor leukemia in the E-mu-ret mouse.
Zeng XX; Zhang H; Hardy RR; Wasserman R
Blood; 1998 Nov; 92(10):3529-36. PubMed ID: 9808544
[TBL] [Abstract][Full Text] [Related]
3. Mouse ret finger protein (rfp) proto-oncogene is expressed at specific stages of mouse spermatogenesis.
Cao T; Shannon M; Handel MA; Etkin LD
Dev Genet; 1996; 19(4):309-20. PubMed ID: 9023983
[TBL] [Abstract][Full Text] [Related]
4. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene.
Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M
Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550
[TBL] [Abstract][Full Text] [Related]
5. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
6. A RING finger motif regulates transforming activity of the rfp/ret fusion gene.
Hasegawa N; Iwashita T; Asai N; Murakami H; Iwata Y; Isomura T; Goto H; Hayakawa T; Takahashi M
Biochem Biophys Res Commun; 1996 Aug; 225(2):627-31. PubMed ID: 8753810
[TBL] [Abstract][Full Text] [Related]
7. TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice.
Tsuzuki S; Seto M
Stem Cells; 2013 Feb; 31(2):236-47. PubMed ID: 23135987
[TBL] [Abstract][Full Text] [Related]
8. Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
Iwamoto T; Pu M; Ito M; Takahashi M; Isobe K; Nagase F; Kawashima K; Ichihara M; Nakashima I
Eur J Immunol; 1991 Aug; 21(8):1809-14. PubMed ID: 1868872
[TBL] [Abstract][Full Text] [Related]
9. The tyrosinase related protein-1 (Tyrp1) promoter in transgenic experiments: targeted expression to the retinal pigment epithelium.
Beermann F
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):961-8. PubMed ID: 10644000
[TBL] [Abstract][Full Text] [Related]
10. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A
Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903
[TBL] [Abstract][Full Text] [Related]
11. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
[TBL] [Abstract][Full Text] [Related]
12. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
Castellone MD; Cirafici AM; De Vita G; De Falco V; Malorni L; Tallini G; Fagin JA; Fusco A; Melillo RM; Santoro M
Oncogene; 2003 Jan; 22(2):246-55. PubMed ID: 12527893
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.
Ta VB; de Bruijn MJ; ter Brugge PJ; van Hamburg JP; Diepstraten HJ; van Loo PF; Kersseboom R; Hendriks RW
Blood; 2010 Feb; 115(7):1385-93. PubMed ID: 20008789
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
15. The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia.
Farrokhi A; Atre T; Rever J; Fidanza M; Duey W; Salitra S; Myung J; Guo M; Jo S; Uzozie A; Baharvand F; Rolf N; Auer F; Hauer J; Grupp SA; Eydoux P; Lange PF; Seif AE; Maxwell CA; Reid GSD
Leukemia; 2024 May; 38(5):969-980. PubMed ID: 38519798
[TBL] [Abstract][Full Text] [Related]
16. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
Drosten M; Hilken G; Böckmann M; Rödicker F; Mise N; Cranston AN; Dahmen U; Ponder BA; Pützer BM
J Natl Cancer Inst; 2004 Aug; 96(16):1231-9. PubMed ID: 15316058
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
Iwamoto T; Taniguchi M; Wajjwalku W; Nakashima I; Takahashi M
Br J Cancer; 1993 Mar; 67(3):504-7. PubMed ID: 8439501
[TBL] [Abstract][Full Text] [Related]
18. A thyroid tumor-specific antigen formed by the fusion of two self proteins.
Powell DJ; Eisenlohr LC; Rothstein JL
J Immunol; 2003 Jan; 170(2):861-9. PubMed ID: 12517951
[TBL] [Abstract][Full Text] [Related]
19. Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice.
Gestblom C; Sweetser DA; Doggett B; Kapur RP
Am J Pathol; 1999 Dec; 155(6):2167-79. PubMed ID: 10595945
[TBL] [Abstract][Full Text] [Related]
20. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
